Private equity has an increasing influence in the ASC industry as investors see opportunity in ASCs as a high-quality, low-cost site of service.
Author: Patsy Newitt
Supply chain disruptions aren't expected to ease for a while, and ASC leaders have been facing obstacles to securing supplies since early in the COVID-19 pandemic.
At least four anesthesiologists made headlines in the last two weeks, including a New York physician who admitted to buying prescription medicine for a profit and an Illinois anesthesiologist running for office.
From physician influence to fear of COVID-19 infection, 17 ASC leaders joined Becker's to discuss what's drawing patients to ASCs over hospitals.
Lebanon, N.H.-based Dartmouth Health is seeking approval for a $13 million ASC expansion on its main campus, Valley News reported June 8.
Eighty-five percent of providers cited cost as a drawback to hiring temporary physicians, according to AMN Healthcare's "2022 Survey of Locum Tenens."
About 70 percent of physicians think some version of a single-payer healthcare system is best for the U.S., according to Medscape's "Physicians' Views on Today's Divisive Social Issues Report 2022."
Capital Real Estate Group’s U.S. Healthcare Investment Sales has sold a two-building medical office and ASC portfolio in Warners Robins, Ga., for $8.3 million, the real estate company told Becker's June 9.
As spine surgeries increasingly migrate to the outpatient setting, ASC leaders are keeping an eye on new technologies changing the way these procedures are performed.
Northside Hospital Gwinnett in Lawrenceville, Ga., is expanding its ambulatory surgery offerings with a $400 million patient tower and medical office building, The Atlanta Journal-Constitution reported June 8.
